Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against ß-Catenin-activated Hepatocellular Carcinoma
Excerpt:
In HCC cell lines with a constitutively activated β-catenin, C-82 inhibited cell proliferation....Moreover, C-82 treatment significantly decreased the expression of cell proliferating markers and increased the expression of apoptosis-related proteins.